Literature DB >> 31340167

Functional variants of autophagy-related genes are associated with the development of hepatocellular carcinoma.

Mingyang Shen1, Lin Lin2.   

Abstract

AIMS: Hepatocellular carcinoma (HCC) is the most common primary liver cancer, and accounts for substantial morbidity and mortality. Autophagy plays an essential role in the development and progression of HCC. This study aims to evaluate whether genetic variants in autophagy-related genes (ATGs) affect the development of HCC.
MATERIALS AND METHODS: We conducted a case-control study with 986 HCC cases and 1000 healthy controls to analyze 14 functional variants of five ATGs (ATG3, ATG5, ATG10, ATG12 and ATG16L1) among a Chinese population. KEY
FINDINGS: We found ATG5 rs17067724 (G vs A: OR = 0.80; 95% CI = 0.65-0.98; P = 0.031), ATG10 rs1864183 (G vs A: OR = 1.29; 95% CI = 1.07-1.57; P = 0.009), ATG10 rs10514231 (C vs T: OR = 1.41; 95% CI = 1.15-1.73; P = 0.001), ATG12 rs26537 (C vs T: OR = 1.16; 95% CI = 1.02-1.33; P = 0.030), and ATG16L1 rs4663402 (T vs A: OR = 1.28; 95% CI = 1.01-1.63; P = 0.044) were significantly associated with HCC risk. Specifically, ATG10 rs10514231 kept significant association even adjusted for Bonferroni correction (P = 0.001 × 14 = 0.014). Bioinformatics analyses showed that allele C of ATG10 rs10514231 was significantly correlated with higher expression of ATG10 gene in both HCC tissues and normal liver tissues. Dual-luciferase reporter assay presented that cell lines transfected with vectors containing the risk allele C of rs10514231 showed higher relative luciferase activity compared to that containing the allele T. SIGNIFICANCE: These results suggested that ATG10 rs10514231 might contribute to an allele-specific effect on the expression of host gene ATG10 and explain a fraction of HCC genetic susceptibility. Our study would benefit the construction of early warning model, early prevention, screening, even therapeutic target of HCC.
Copyright © 2019. Published by Elsevier Inc.

Entities:  

Keywords:  Autophagy; Expression quantitative trait loci; Genetic; Hepatocellular carcinoma

Mesh:

Substances:

Year:  2019        PMID: 31340167     DOI: 10.1016/j.lfs.2019.116675

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  8 in total

1.  Polymorphisms in autophagy genes are genetic susceptibility factors in glioblastoma development.

Authors:  E Bueno-Martínez; M Lara-Almunia; C Rodríguez-Arias; A Otero-Rodríguez; S Garfias-Arjona; R González-Sarmiento
Journal:  BMC Cancer       Date:  2022-02-05       Impact factor: 4.430

2.  Cholesterol sensor SCAP contributes to sorafenib resistance by regulating autophagy in hepatocellular carcinoma.

Authors:  Danyang Li; Yingcheng Yao; Yuhan Rao; Xinyu Huang; Li Wei; Zhimei You; Guo Zheng; Xiaoli Hou; Yu Su; Zac Varghese; John F Moorhead; Yaxi Chen; Xiong Z Ruan
Journal:  J Exp Clin Cancer Res       Date:  2022-03-30

3.  Associations between ATG16L1 gene polymorphism and antineutrophil cytoplasmic antibody-associated vasculitis in the Chinese Guangxi population: A case-control study.

Authors:  Bing-Mei Feng; Chao Xue; Hai-Zheng Huang; Yu-Gan Lu; Tao Feng; Xue-Yi Huang; Wei Li
Journal:  J Clin Lab Anal       Date:  2022-08-10       Impact factor: 3.124

Review 4.  Sorafenib Resistance in Hepatocellular Carcinoma: The Relevance of Genetic Heterogeneity.

Authors:  Loraine Kay D Cabral; Claudio Tiribelli; Caecilia H C Sukowati
Journal:  Cancers (Basel)       Date:  2020-06-15       Impact factor: 6.639

5.  Four Autophagy-Related lncRNAs Predict the Prognosis of HCC through Coexpression and ceRNA Mechanism.

Authors:  Hao Wu; Tiantian Liu; Jianni Qi; Chengyong Qin; Qiang Zhu
Journal:  Biomed Res Int       Date:  2020-10-09       Impact factor: 3.411

Review 6.  Pathogenic Single Nucleotide Polymorphisms on Autophagy-Related Genes.

Authors:  Isaac Tamargo-Gómez; Álvaro F Fernández; Guillermo Mariño
Journal:  Int J Mol Sci       Date:  2020-11-02       Impact factor: 5.923

7.  Ubiquitin-related molecular classification and risk stratification of hepatocellular carcinoma.

Authors:  Si Yang; Bowen Yao; Liming Wu; Yuanxing Liu; Kang Liu; Peng Xu; Yi Zheng; Yujiao Deng; Zhen Zhai; Ying Wu; Na Li; Dai Zhang; Huafeng Kang; Zhijun Dai
Journal:  Mol Ther Oncolytics       Date:  2021-04-17       Impact factor: 7.200

Review 8.  Genetic Heterogeneity, Therapeutic Hurdle Confronting Sorafenib and Immune Checkpoint Inhibitors in Hepatocellular Carcinoma.

Authors:  Sara M Atwa; Margarete Odenthal; Hend M El Tayebi
Journal:  Cancers (Basel)       Date:  2021-08-27       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.